发明名称 |
MULTIPLE ADMINISTRATIONS OF ANTI-TNF ANTIBODY |
摘要 |
The invention relates to a method of treating an individual having a TNF-mediated disease comprising administering to the individual multiple doses of an anti-TNF antibody wherein the second or subsequent dose is administered during or immediately prior to relapse of the disease. Preferably, the disease is a TNF alpha -mediated disease, such as rheumatoid arthritis. The anti-TNF antibody can be a monoclonal antibody or fragment thereof, such as a murine antibody, chimeric antibody or a humanized antibody or fragment thereof. Preferably, the antibody binds to one or more amino acids of human TNF alpha (hTNF alpha ) selected from the group consisting of 87-108 and 59-80. The antibody can bind to the epitope of A2 or cA2. In a preferred embodiment, the antibody is A2 or cA2. |
申请公布号 |
EP0871641(A1) |
申请公布日期 |
1998.10.21 |
申请号 |
EP19950917696 |
申请日期 |
1995.04.20 |
申请人 |
KENNEDY INSTITUTE OF RHEUMATOLOGY;CENTOCOR, INC. |
发明人 |
FELDMANN, MARC;MAINI, RAVINDER, NATH;WOODY, JAMES, N. |
分类号 |
A61K38/00;A61K39/395;C07H21/00;C07K14/525;C07K16/24;C07K16/42;C07K16/46 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|